In brief: Takeda completes £46bn Shire acquisition

In brief: Ipsen closes Clementia acquisition

Having cleared all the regulatory hurdles and secured strong shareholder backing, Japan’s Takeda has completed its game-changing £46 billion acquisition of Shire.

The deal – originally announced back in May 2018 – grants Takeda a significantly expanded geographical footprint and positions it among the top ten pharmaceutical companies in the world.

Christophe Weber, President and CEO of Takeda, said: “This marks a significant moment in Takeda’s history and is an exciting step forward as we accelerate our transformation journey to deliver highly-innovative medicines to patients around the world with expanded scale and geographical footprint.”